Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis

B Wei, R Zhang, H Zeng, L Wu, R He… - Expert Review of Anti …, 2023 - Taylor & Francis
Background We aimed to assess the impact of antiviral drugs (fluvoxamine, remdesivir,
lopinavir/ritonavir (LPV/r), molnupiravir, andnirmatrelvir/ritonavir (NRV/r)) on health care …

[HTML][HTML] Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence

I Karniadakis, N Mazonakis, C Tsioutis… - Infectious Disease …, 2023 - mdpi.com
Vaccines remain the cornerstone of medical prevention and are highly effective in reducing
the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the …

Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19

JY Wu, MY Liu, TH Liu, MH Chuang… - Journal of Medical …, 2023 - Wiley Online Library
The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …

SARS-CoV-2 genomics and impact on clinical care for COVID-19

R Lorenzo-Redondo… - Journal of …, 2023 - academic.oup.com
The emergence and worldwide spread of SARS-CoV-2 during the COVID-19 pandemic
necessitated the adaptation and rapid deployment of viral WGS and analysis techniques that …

Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2)

I Sommer, D Ledinger, K Thaler… - Annals of internal …, 2023 - acpjournals.org
Background: Clinicians and patients want to know the benefits and harms of outpatient
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …

[HTML][HTML] Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients

SF Tey, YW Tsai, JY Wu, TH Liu, MH Chuang… - Frontiers in Public …, 2024 - frontiersin.org
Background The outcomes of older adult people acquiring SARS-CoV-2 reinfection was
unclear. This study aimed to compare the outcomes of older adult patients with COVID-19 …

Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis

B Amani, B Amani - Immunity, Inflammation and Disease, 2024 - Wiley Online Library
Abstract Background and Aim This systematic review and meta‐analysis aimed to compare
the effectiveness and safety of molnupiravir and sotrovimab in the treatment of patients with …

[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer

WH Hsu, BW Shiau, YW Tsai, JY Wu, PY Huang… - Journal of Infection and …, 2024 - Elsevier
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …

[HTML][HTML] Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis

HA Cheema, SA Rab, M Butt, U Jafar, A Shahid… - Journal of Microbiology …, 2024 - Elsevier
Background The majority of available data on molnupiravir come from an unvaccinated
COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence …

Response to the letter to the editor on" Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review …

PY Huang, TH Liu, JY Wu… - Journal of medical …, 2023 - pubmed.ncbi.nlm.nih.gov
Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for
nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis …